COMP <GO>
FLGT vs UNH // ALTMAN Z-SCORE & DEBT/EQUITY
Fulgent Genetics Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: FLGT 2
— UNH 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: FLGT
LAST: $20.62 (-4.89%) • MKT CAP: $596.5M
balance-sheet
4.44
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
balance-sheet
3.12
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLGT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FLGT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.60% | 88.57% | -47.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.80% | 11.47% | -18.27 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -20.82% | 6.48% | -27.30 | UNH | /fcf-yield <GO> |
| Operating Margin | -28.20% | 4.82% | -33.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | -18.80% | 3.14% | -21.94 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.80% | 6.46% | +7.34 | FLGT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.44 | 3.12 | +1.32 | FLGT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.3 | 59.2 | -2.90 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $596.5M | $368.83B | -$368.23B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FLGT REV | UNH REV | FLGT GROSS % | UNH GROSS % | FLGT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $322.7M | $447.57B | 40.6% | 88.7% | -$124.2M | $16.07B |
| FY 2024 | $283.5M | $400.28B | 37.8% | 88.3% | -$19.3M | $20.70B |
| FY 2023 | $289.2M | $371.62B | — | 89.6% | $27.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLGT // BETA —
UNH // BETA 0.33